Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case

Central serous chorioretinopathy (CSCR) is potentially sight-threatening and has been associated with corticosteroid use. CSCR secondary to steroid use can sometimes be challenging to treat, especially if continuing steroid use is medically necessary. In this case report we demonstrate the efficacy...

Full description

Bibliographic Details
Main Authors: Kapil G. Kapoor, Jennifer Sim
Format: Article
Language:English
Published: Karger Publishers 2017-07-01
Series:Case Reports in Ophthalmology
Subjects:
Online Access:http://www.karger.com/Article/FullText/477757
_version_ 1818559251631570944
author Kapil G. Kapoor
Jennifer Sim
author_facet Kapil G. Kapoor
Jennifer Sim
author_sort Kapil G. Kapoor
collection DOAJ
description Central serous chorioretinopathy (CSCR) is potentially sight-threatening and has been associated with corticosteroid use. CSCR secondary to steroid use can sometimes be challenging to treat, especially if continuing steroid use is medically necessary. In this case report we demonstrate the efficacy of spironolactone as an effective agent in countering CSCR secondary to steroid use. This challenge-rechallenge case may be helpful to clinicians in delineating a treatment paradigm for these patients.
first_indexed 2024-12-14T00:22:59Z
format Article
id doaj.art-a7d48e39f0e4474898d8ca92cbb4154d
institution Directory Open Access Journal
issn 1663-2699
language English
last_indexed 2024-12-14T00:22:59Z
publishDate 2017-07-01
publisher Karger Publishers
record_format Article
series Case Reports in Ophthalmology
spelling doaj.art-a7d48e39f0e4474898d8ca92cbb4154d2022-12-21T23:25:09ZengKarger PublishersCase Reports in Ophthalmology1663-26992017-07-018237037410.1159/000477757477757Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge CaseKapil G. KapoorJennifer SimCentral serous chorioretinopathy (CSCR) is potentially sight-threatening and has been associated with corticosteroid use. CSCR secondary to steroid use can sometimes be challenging to treat, especially if continuing steroid use is medically necessary. In this case report we demonstrate the efficacy of spironolactone as an effective agent in countering CSCR secondary to steroid use. This challenge-rechallenge case may be helpful to clinicians in delineating a treatment paradigm for these patients.http://www.karger.com/Article/FullText/477757Central serous chorioretinopathySpironolactoneCorticosteroids
spellingShingle Kapil G. Kapoor
Jennifer Sim
Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case
Case Reports in Ophthalmology
Central serous chorioretinopathy
Spironolactone
Corticosteroids
title Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case
title_full Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case
title_fullStr Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case
title_full_unstemmed Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case
title_short Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case
title_sort spironolactone for secondary central serous chorioretinopathy a challenge rechallenge case
topic Central serous chorioretinopathy
Spironolactone
Corticosteroids
url http://www.karger.com/Article/FullText/477757
work_keys_str_mv AT kapilgkapoor spironolactoneforsecondarycentralserouschorioretinopathyachallengerechallengecase
AT jennifersim spironolactoneforsecondarycentralserouschorioretinopathyachallengerechallengecase